EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,024,664 | +25.0% | 2,884,424 | +9.3% | 0.01% | +25.0% |
| Q2 2023 | $50,408,724 | -78.3% | 2,637,819 | -77.9% | 0.00% | -63.6% |
| Q1 2023 | $231,829,104 | +10.8% | 11,943,798 | -8.5% | 0.01% | -47.6% |
| Q4 2022 | $209,324,860 | -14.3% | 13,050,178 | -16.2% | 0.02% | -16.0% |
| Q3 2022 | $244,256,000 | -32.6% | 15,577,570 | -10.5% | 0.02% | -30.6% |
| Q2 2022 | $362,212,000 | -7.1% | 17,397,286 | +1.1% | 0.04% | +16.1% |
| Q1 2022 | $389,925,000 | +13.4% | 17,200,032 | -8.5% | 0.03% | +24.0% |
| Q4 2021 | $343,755,000 | -13.6% | 18,804,980 | -0.0% | 0.02% | -21.9% |
| Q3 2021 | $397,717,000 | +8.6% | 18,813,482 | -6.4% | 0.03% | +10.3% |
| Q2 2021 | $366,251,000 | +7.0% | 20,101,588 | +32.6% | 0.03% | 0.0% |
| Q1 2021 | $342,410,000 | +33.8% | 15,157,608 | +18.9% | 0.03% | +26.1% |
| Q4 2020 | $255,894,000 | -15.7% | 12,750,071 | +2.7% | 0.02% | -25.8% |
| Q3 2020 | $303,512,000 | +214.2% | 12,413,589 | +205.1% | 0.03% | +181.8% |
| Q2 2020 | $96,588,000 | -3.2% | 4,068,592 | -29.8% | 0.01% | -21.4% |
| Q1 2020 | $99,771,000 | -42.0% | 5,793,890 | -40.6% | 0.01% | -26.3% |
| Q4 2019 | $171,920,000 | -25.0% | 9,757,107 | -24.7% | 0.02% | -29.6% |
| Q3 2019 | $229,226,000 | -34.7% | 12,961,569 | -21.1% | 0.03% | -34.1% |
| Q2 2019 | $351,225,000 | -28.5% | 16,435,445 | -20.4% | 0.04% | -30.5% |
| Q1 2019 | $491,210,000 | +17.1% | 20,639,046 | -3.2% | 0.06% | +3.5% |
| Q4 2018 | $419,323,000 | -4.0% | 21,317,889 | -13.5% | 0.06% | +16.3% |
| Q3 2018 | $436,725,000 | -30.2% | 24,645,936 | -15.2% | 0.05% | -31.9% |
| Q2 2018 | $625,249,000 | -16.8% | 29,054,302 | -14.4% | 0.07% | -19.1% |
| Q1 2018 | $751,851,000 | -32.1% | 33,943,665 | -6.8% | 0.09% | -31.5% |
| Q4 2017 | $1,107,760,000 | +8.9% | 36,439,460 | -13.2% | 0.13% | +5.7% |
| Q3 2017 | $1,016,928,000 | -5.6% | 41,969,832 | -4.1% | 0.12% | -8.2% |
| Q2 2017 | $1,077,530,000 | +15.9% | 43,748,695 | +2.0% | 0.13% | +13.6% |
| Q1 2017 | $929,453,000 | +45.3% | 42,891,243 | -0.0% | 0.12% | +37.2% |
| Q4 2016 | $639,789,000 | +44.8% | 42,910,087 | +24.2% | 0.09% | +45.8% |
| Q3 2016 | $441,880,000 | +64.9% | 34,548,861 | +0.7% | 0.06% | +59.5% |
| Q2 2016 | $267,969,000 | +95.7% | 34,310,948 | +0.2% | 0.04% | +94.7% |
| Q1 2016 | $136,914,000 | -28.8% | 34,228,669 | +0.4% | 0.02% | -26.9% |
| Q4 2015 | $192,225,000 | +1.3% | 34,082,482 | +0.8% | 0.03% | -3.7% |
| Q3 2015 | $189,700,000 | +229.3% | 33,814,661 | +120.7% | 0.03% | +285.7% |
| Q2 2015 | $57,610,000 | +38.1% | 15,321,741 | -5.6% | 0.01% | +40.0% |
| Q1 2015 | $41,720,000 | +75.2% | 16,233,341 | -1.8% | 0.01% | +66.7% |
| Q4 2014 | $23,811,000 | -9.2% | 16,535,441 | -3.5% | 0.00% | -25.0% |
| Q3 2014 | $26,217,000 | -73.5% | 17,135,441 | -41.3% | 0.00% | -69.2% |
| Q2 2014 | $99,002,000 | -4.2% | 29,204,242 | +0.0% | 0.01% | -7.1% |
| Q1 2014 | $103,341,000 | -39.0% | 29,192,145 | +5.7% | 0.01% | -41.7% |
| Q4 2013 | $169,377,000 | +8.5% | 27,630,658 | +3.0% | 0.02% | 0.0% |
| Q3 2013 | $156,088,000 | +28.2% | 26,819,117 | 0.0% | 0.02% | +20.0% |
| Q2 2013 | $121,759,000 | – | 26,819,117 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |